DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

89.38 -0.07 (-0.08%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $89.38 -0.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.55
Previous Close $89.45
Daily Range $88.01 - $89.95
52-Week Range $55.04 - $91.40
Market Cap $13.2B
P/E Ratio -101.65
Dividend (Yield) $0.00 (0.0%)
Volume 920,243
Average Daily Volume 1,204,016
Current FY EPS -$1.06

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE

Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Anal

Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Rolling With Biotech's Regulatory Punches: Chen Lin

New Lifetime High Today: Biomarin Pharmaceutical (BMRN)

RBC Has Three Top Biotech Picks for Year End and 2015

Benzinga's M&A Chatter for Monday November 24, 2014

Closing Update: Stocks Extend Winning Streak to Third Day

S&P 500 Little Changed Amid Uncertainty Over U.S. Economic Growth

See More BMRN News...

BMRN's Top Competitors

BMRN $89.38 (-0.08%)
Current stock: BMRN
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB